Funding HIV and AIDS in South Africa Professor Alan Whiteside

Slides:



Advertisements
Similar presentations
The Effectiveness of Global Health Partnerships Findings and Lessons from a World Bank Evaluation of Global Health Programs Uma Lele April 14, 2005.
Advertisements

HIV/AIDS Major effects on women and children in developing countries.
Fast-track to ending AIDS in Zimbabwe: opportunities
Is HIV/AIDS still exceptional? Alan Whiteside Health Economics and HIV/AIDS Research Division, University of KwaZulu-Natal Durban Presentation to Daniel.
UNAIDS, Regional Support Team, Eastern and Southern Africa
HIV and the Financial Crisis Academic Council Debate on the Financial Crisis and Public Health Robert Greener, April 30, 2009.
Overview of HIV & AIDS in Africa
WHAT IS GOING ON IN HIV AND AIDS IN 2013 AND BEYOND Prof Alan Whiteside RATN MEETING JOHANNESBURG March 2013.
ADF: Impact of HIV/AIDS and Governance by Prof. Alan Whiteside Commissioner CHGA The Epidemic and its Consequences for Africa.
HIV Therapy for the Developing World: A Global Health Challenge Harold W. Jaffe, MD Department of Public Health University of Oxford Oxford, UK.
Tracking Expenditure for HIV and AIDS in Africa ~ Cross-Country Comparisons Guthrie, T., Kioko, U. Inaugural Conference of the African Health Economics.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Bhutan.
Antiretroviral Treatment (ART) & Human resources Wim Van Damme Department of Public Health ITM, 17 October 2006.
Scientists determined that AIDS originated in Central Africa around 1930 More than 70% of the victims of AIDS were Africans A quarter of the people who.
Enabling Continuity of a Public Health ARV Treatment program in a resource limited setting: The Case of the transition of the African Comprehensive HIV/AIDS.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
The Health Crisis In Developing Nations. Lack of Clean Water  1.2 billion people around the world lack access to clean water.  Why?  Open water sources.
World Bank Seminar Series: Global Issues Facing Humanity Diseases without borders.
 HIV and AIDS prevalence in the Middle East and North Africa is around 0.2% ( %) with between 230,000 and 1.4 million people infected.  Among.
HIV/AIDS Epidemic Disproportionately Affects Women.
AIDS in Sub Saharan Africa AIDS – a virus with no known cure first identified in the Belgian Congo in It’s now a global epidemic, and poverty and.
The State of the Epidemic in 2010 by Professor Alan Whiteside HEARD House of Lords 9 th March 2010 DFID HIV Leaders Meeting.
1 Domestic Financing for Health Parliamentarian Round Table March 2014,Joburg, SA Linda Mafu, Head Political Advocacy and Civil Society Department,
PEPFAR Investment Strategy (8 years of PEPFAR) Data source : OGAC Budget Total PEPFAR Investment: $21,285,918,291 Saving Lives : Changing the.
Economics 172 Issues in African Economic Development Lecture 8 February 9, 2006.
Securing the future today Synthesis of strategic information on HIV and young people Global Interagency Task Team on HIV and young people, June 2011.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Timor-Leste Last updated: December 2014.
Plan © Plan HIV/AIDS. © Plan 2 Average life expectancy in 11 African Countries (age in years) Country/ 国家 Before AIDS/ 流行前 2010 Angola Botswana
HIV and AIDS Data Hub for Asia-Pacific Review in slides India.
Distribution of Number of People Infected with HIV Total = 10.7 million in 2000.
Where services are needed The number of women and girls who were newly infected with HIV in Note: For Botswana and Zimbabwe, the number of women.
What we know about the Impact of HIV/AIDS on Teachers: a general overview by Alan Whiteside and Peter Badcock- Walters Health Economics and HIV/AIDS Research.
1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)
Estimating the Impact and Needs for Children and PMTCT Making sense: Understanding the numbers: from HIV surveillance to national and global HIV burden.
Projected Population and HIV/AIDS Update 18 May 2011 National Health Insurance Policy Brief 18.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Timor-Leste.
2008 International AIDS Conference UNGASS reporting Matthew Warner-Smith Monitoring and Evaluation Division UNAIDS 2008 International AIDS Conference Satellite.
Dr Rachel Yates Senior Adviser, UNICEF HIV/AIDS section New York OWN, SCALE-UP & SUSTAIN The 16 th International Conference on AIDS & STIs in Africa 4.
1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)
Global Impact of HIV/AIDS Deborah Lewinsohn, M.D. Infectious Diseases, Pediatrics Vaccine and Gene Therapy Institute Oregon Health & Science University.
Resource Availability for HIV, Overview of the financing situation
Peter D Ghys*, Mary Mahy*, Jeff Eaton**, Samir Bhatt**,
Contents - HIV global slides
Sri Lanka Last updated: September 2016.
Number of people receiving antiretroviral therapy in
The State of the Epidemic in 2010
Overview of Global HIV Epidemic
Mongolia Last updated: April 2016.
Ambassador Deborah L. Birx, MD
World Health Organization
THE EXPLODING GLOBAL HIV/AIDS PANDEMIC
Key Affected Populations
Tiffany G. Harris, PhD, MS Director of Strategic Information
GOVERNMENT SS7CG3 The student will analyze how politics in Africa impacts the standard of living.
Contents - HIV global slides
HIV \ AIDS Distribution.
Forecasting the Cost of Financing ART in Sub-Saharan Africa under Differential Funding Scenarios Tahvi Frank and Austin Carter July 25, 2018.
China 2010 UNGASS Country Progress Report
Showing throughout the event
Financing South Africa’s HIV Response
Contents - HIV global slides
Bhutan.
Myanmar Last Update: November 2014.
2007 World Population Data Sheet
Contents - HIV global slides
Progress on Voluntary Medical Male Circumcision for HIV prevention and How VMMC fits into UNAIDS ' ' target Julia Samuelson, Nurse epidemiologist.
Brunei Darussalam Last updated: April 2019.
Japan Last updated: April 2019.
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

Funding HIV and AIDS in South Africa Professor Alan Whiteside Slides borrowed from Teresa Guthrie AIDS 2031 Zapiro; Harris 20th October 2009

Demographic and Health Survey HIV Prevalence: Swaziland From DHS – can see sharp rise in infections once become sexually active and gendered aspect. This suggests that upon becoming sexually active the chances of a women becoming infected at a young age are extremely high. Thus, her children have a high probability of being orphaned at a very young age. These results also present the worrying indication that half of all women aged 25-29 are HIV positive. Rates among men do not seem to rise substantially until the 30-34 year age group where around 45% of men are HIV positive. Life time risk - This examines the likelihood of an individual becoming infected with HIV throughout their lifetimes, as prevalence rates for older age groups are not only the ageing of younger infections, but also include a percentage of new infections, therefore the chances therefore of becoming infected while in each age group are cumulative throughout an individuals lifetime. UNAIDS (2000) suggest that in countries such as South Africa and Zimbabwe where a quarter of the adult population is infected, AIDS will claim the lives of around half of all 15 year olds. This increases to two thirds of all 15 year olds in countries with higher prevelance, such as Swaziland and Botswana.

Funding questions How much? And it is expensive! Where from? typical health funding mix private/public/out of pocket Donor/government but we are not Malawi What are choices and priorities? For the hospital The province The national government The world Who chooses and how? Democratic Donor Stalinist In the medium to long term, there exists potential sources of risk that may disrupt funding for health and expenditure on health. Domestic and external sources of funding will be affected by different types of risks. Treatment, prevention, care and support strategies will be affected depending on the source of funds, as well as the frequency and depth of such risks

Global funding for HIV and AIDS: the current picture Source: UNAIDS. ‘What Countries Need, Investments Needed for 2010 Targets’ 2009

What we know is predictable Future demand for health services and the requisite supply of health services (treatment, care, support, prevention) is predictable. The ‘waves’ of the HIV and AIDS epidemic in S.Africa can be modelled with good accuracy Source: Dorrington et al. The Demographic Impact of HIV/AIDS in South Africa. Center for Actuarial Research, 2006.

What we know is predictable: ‘deaths’ Projected number of AIDS deaths in South Africa by level of ART coverage Source: Dorrington et al. The Demographic Impact of HIV/AIDS in South Africa. Center for Actuarial Research, 2006.

Prevention: cholera to swine flu 10

AIDS: Mopping the Floor while the tap is running

Global Responsibilities: treatment rights and funding Funds can dissapear and funding can dry-up. Zambia’s main aid donors suspended aid in May 2009 after confirmations of corruption by senior government officials Funding crisis in August 2009 severaly affected ARV treatment clinics in the Free State province of S.Africa. Donor disorders: accountability standards that are applied to developing country recipients; industry The people that suffer are those who are denied treatment after previously being on drugs and who are denied treatment altogether. Interruptions to treatment leads to drug resistance, and therefore greater costs.

Global Responsibilities: long term commitments Donor funding has 3-5 year time horizons It is critical to shift away from short-term emergency health aid, towards long-term health development that is sustainable But donors will not fund chronic conditions which are seen as life style: eg obesity, smoking The consequences of climate change will be long wave event, and the world recognises that resources will be needed for very long term Global health responsibilities needs global commitment: - the global response to SARS and swine-flu was quick and comprehensive - the UK will pay close to a billion pounds for flu vaccinations

Funding (un)predictability Long-term global financing is unpredictable Donor funding is time bound Domestic (South African) is predictable but not sufficient Ways forward DART Trial More for our money Move to an AIDS economy – sea changes in the way we do things and see things PREVENTION PREVENTION PREVENTION In the medium to long term, there exists potential sources of risk that may disrupt funding for health and expenditure on health. Domestic and external sources of funding will be affected by different types of risks. Treatment, prevention, care and support strategies will be affected depending on the source of funds, as well as the frequency and depth of such risks